August 1998
Volume 39, Issue 9
Free
Articles  |   August 1998
Alpha2-adrenergic agonists selectively activate extracellular signal-regulated kinases in Müller cells in vivo.
Author Affiliations
  • M Peng
    Department of Ophthalmology, University of Pennsylvania, School of Medicine, Philadelphia 19104, USA.
  • Y Li
    Department of Ophthalmology, University of Pennsylvania, School of Medicine, Philadelphia 19104, USA.
  • Z Luo
    Department of Ophthalmology, University of Pennsylvania, School of Medicine, Philadelphia 19104, USA.
  • C Liu
    Department of Ophthalmology, University of Pennsylvania, School of Medicine, Philadelphia 19104, USA.
  • A M Laties
    Department of Ophthalmology, University of Pennsylvania, School of Medicine, Philadelphia 19104, USA.
  • R Wen
    Department of Ophthalmology, University of Pennsylvania, School of Medicine, Philadelphia 19104, USA.
Investigative Ophthalmology & Visual Science August 1998, Vol.39, 1721-1726. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M Peng, Y Li, Z Luo, C Liu, A M Laties, R Wen; Alpha2-adrenergic agonists selectively activate extracellular signal-regulated kinases in Müller cells in vivo.. Invest. Ophthalmol. Vis. Sci. 1998;39(9):1721-1726.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
This content is PDF only. Please click on the PDF icon to access.
Abstract

PURPOSE: Alpha2-adrenergic agonists have specific and selective effects on the retina to induce expression of basic fibroblast growth factor and to protect photoreceptors. This work explores the signaling pathway that mediates these effects. METHODS: Alpha2-adrenergic agonists xylazine and clonidine were administered systemically to male adult Sprague-Dawley rats. The activation state of extracellular signal-regulated kinases (ERKs) in the retina was assessed by immunoblot analysis, using antibodies that specifically recognize the dually phosphorylated forms of p44/p42 ERKs. Localization of phosphorylated ERKs was determined by immunocytochemistry. RESULTS: Intramuscular injection of 6 mg/kg xylazine induced an increase in ERK phosphorylation in the retina within 30 minutes that lasted 3 hours. Xylazine induced ERK phosphorylation at 1 mg/kg and reached a maximum at 10 mg/kg. Injection of clonidine also induced ERK phosphorylation in the retina. Yohimbine, a specific alpha2-adrenergic antagonist, completely prevented the induction of ERK phosphorylation. Immunocytochemical studies showed that the increase in ERK phosphorylation occurred mainly in Müller cells. In the brain, xylazine injection resulted in a decrease in ERK phosphorylation. CONCLUSIONS: Our results indicate that systemically administered alpha2-adrenergic agonists selectively activate ERKs in retinal Müller cells. The induced activation of ERKs in Müller cells is probably one of the early events that result in photoreceptor protection. These results also indicate that Müller cells are unique in response to alpha2-adrenergic agonists and imply a role for Müller cells in alpha2-adrenergic agonist-induced photoreceptor protection.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×